Market evolution: Cyclic alcohols (CN 290619) — 2015–2025

Introduction

This report examines the trade dynamics of cyclanic, cyclenic or cycloterpenic alcohols and their derivatives (Combined Nomenclature code 290619) within the European Union over the 2015–2025 period. This residual subheading covers a broad range of specialty cyclic alcohols — excluding widely traded items such as menthol, cyclohexanol, and sterols — and serves as an important input for the pharmaceutical, fragrance, and fine-chemical industries.

Over the past decade, the EU market for CN 290619 has undergone a fundamental transformation. Total imports more than doubled in value, while export growth — though solid — lagged behind, causing the EU's trade balance to swing from a €9.7 million surplus in 2015 to a €33.3 million deficit in 2025. Meanwhile, EU domestic production expanded substantially in both volume and value, pointing to a repositioning toward higher-margin specialty products. The following sections analyse these shifts across three dimensions: the macro trade balance, the geographic reorientation of partners, and the structural evolution of EU production and pricing.

1. The Import Boom and the Reversal of the EU's Trade Balance

The most striking feature of the 2015–2025 period is the dramatic growth of EU imports relative to exports. While both flows increased, the asymmetry was large enough to reverse the EU's trade position entirely.

Trade volumes and values diverge sharply

The table below summarises the evolution of EU extra-EU trade in CN 290619:

Imports grew by 138.3% in value — nearly three times the rate of export growth (45.9%). In volume terms, the gap was even wider: import quantities rose by 87.6% while export volumes barely moved (+5.9%). Both sides experienced unit-price increases, but export prices rose faster (+37.7% versus +26.0% for imports), suggesting that the EU increasingly shipped higher-value cyclic alcohols even as it absorbed larger volumes of less expensive product from abroad.

From surplus to deficit: a €43 million swing

In 2015, the EU enjoyed a modest trade surplus of €9.7 million in CN 290619. By 2025, this had become a deficit of €33.3 million — a deterioration of over €43 million. This was driven almost entirely by the acceleration of imports from 2019 onwards, likely reflecting post-pandemic restocking, growing downstream demand in pharmaceuticals and fragrances, and the increasing competitiveness of Asian suppliers.

Import growth was both volume- and price-driven

Import volumes nearly doubled (+87.6%), indicating that the EU's downstream industries required substantially more cyclic alcohols than domestic production alone could supply — or that sourcing from abroad became more cost-effective. At the same time, import prices rose by 26.0%, suggesting some tightening of global supply or a shift toward higher-grade imported material. The combination of volume expansion and price inflation produced the 138.3% value increase — a powerful double effect that reshaped the market's trade profile in barely a decade.

2. Geographic Reorientation: Asian Suppliers and Switzerland Gain Ground

Behind the headline import surge lies a profound shift in the EU's sourcing geography. Asian producers — particularly China and India — dramatically increased their market share, while Switzerland emerged as a key specialty supplier. On the export side, the EU redirected flows toward fast-growing Asian markets, though some traditional partners lost ground.

China and India became the dominant import suppliers

China alone accounted for €42.9 million in EU imports in 2025 — more than a third of total import value and nearly triple its 2015 level. India's growth was even more dramatic in relative terms (+327.3%), rising from €5.7 million to €24.5 million. South Korea, while starting from a very low base, grew by over 1,500% to €5.5 million.

Switzerland's role is particularly noteworthy: its exports to the EU grew from €5.8 million to €21.6 million (+274.8%). Given Switzerland's strong pharmaceutical and fine-chemicals sector, this likely reflects specialty cyclic alcohol supply — possibly high-purity intermediates for the EU life-sciences industry.

Meanwhile, traditional suppliers Japan and the United States lost ground. Japanese exports to the EU fell by 66.2% (from €4.1 million to €1.4 million), and US exports declined by 25.7%, possibly reflecting competitive pressure from lower-cost Asian producers.

EU exports diversified toward China and India while declining to the UK

The most dramatic export shift was toward China: EU exports surged from just €1.9 million to €10.2 million (+433.8%), making China the EU's third-largest export destination by 2025. India also grew strongly (+134.7%), reflecting the expansion of Indian pharmaceutical manufacturing that requires EU-origin specialty intermediates.

The United States remained the EU's largest single export market, growing by 53.4% to €23.2 million. However, exports to the United Kingdom fell sharply (−61.9%), likely a consequence of Brexit-related trade friction. Switzerland and Japan also saw declining EU export receipts over the period.

Import sourcing became more concentrated; exports diversified

The Herfindahl-Hirschman Index (HHI) of EU imports by value rose from 1,762 to 2,327 (+32.1%), moving the market from a moderately concentrated to a more concentrated structure. This increase was driven by the growing dominance of China and India, which together now account for well over half of import value.

By contrast, the HHI of EU exports by value fell from 1,379 to 1,212 (−12.1%), indicating a gradual diversification of export destinations. The EU's export base became somewhat broader, even as its import base narrowed — a divergence that carries contrasting implications for market resilience.

3. EU Production Expansion, Pricing Power, and Market Volatility

While the import surge dominated trade headlines, the EU's domestic production of cyclic alcohols also expanded significantly. This growth, concentrated in a handful of Member States, occurred alongside notable price differentials between imports and exports and was punctuated by episodic price shocks.

EU production grew in volume and even more so in value

EU production rose from 30,000 to 40,000 tonnes (+33.3%), but the value increase was far steeper at +135.9%, lifting the average production unit value from €4.23/kg to €7.48/kg. This divergence strongly suggests that EU producers shifted their output mix toward higher-value specialty cyclic alcohols — consistent with the broader strategic repositioning of the European chemicals industry toward premium, knowledge-intensive segments.

The most specialised Member States in CN 290619 are Germany (RSCA 0.32, production share 40.8%), Spain (RSCA 0.44, production share 14.8%), and France (RSCA 0.28, production share 13.8%). Germany alone accounts for over 40% of EU production value. Among EU importers, Germany (€36.4 million) and France (€34.5 million) are the largest, followed by Spain (€21.4 million) — all three countries that also feature prominently in exports, indicating substantial intra-industry trade in different cyclic alcohol grades.

A persistent price gap points to intra-industry trade patterns

Throughout the period, EU export unit prices consistently and increasingly exceeded import unit prices:

The export price premium widened from 45.7% in 2015 to 59.3% in 2025. This persistent and growing gap is consistent with a pattern of intra-industry trade: the EU imports larger volumes of lower-grade or commodity cyclic alcohols (notably from China and India) and exports smaller volumes of higher-purity, application-specific derivatives to premium markets such as the United States and Switzerland.

Key trade shocks highlight supply-chain vulnerabilities

The volatility analysis reveals several significant price shocks over the period:

The most extreme shock was a doubling of EU export prices to Japan in 2021 (+105.0%), which may reflect pandemic-era supply disruptions or a compositional shift toward higher-value product grades shipped during a period of constrained supply. The UK export-price shock in 2019 (+64.4%) likely pre-figured Brexit-related trade restructuring. On the import side, a 46.3% price spike from China in 2019 — affecting over half of EU import value — underscores the risk of dependence on a single dominant supplier.

Import volatility, measured by coefficient of variation, was highest for smaller or more erratic suppliers such as Israel (CV 1.65) and the United Kingdom (CV 1.35), while the two largest import partners — Switzerland and China — showed more moderate volatility (CV 0.84 and 0.43 respectively), suggesting more stable commercial relationships.

Conclusion

The EU market for cyclic alcohols (CN 290619) underwent a structural transformation between 2015 and 2025. The most consequential shift was the surge in imports — driven overwhelmingly by China and India — which turned a modest trade surplus into a €33.3 million deficit. Import volumes nearly doubled, reflecting growing downstream demand and the cost-competitiveness of Asian producers.

At the same time, the EU's domestic production base expanded and moved up the value chain. Output grew by a third in volume but more than doubled in value, and the persistent and widening export-price premium indicates that EU producers increasingly focus on high-margin specialty cyclic alcohols. This intra-industry trade pattern — importing commodity grades, exporting premium derivatives — is a hallmark of the European fine-chemicals sector.

Key risks going forward include the growing concentration of import sourcing (rising HHI) and episodic price shocks from dominant suppliers. While EU export markets have diversified somewhat, the heavy reliance on China and, increasingly, India for import supply warrants attention from a strategic-autonomy perspective. The emergence of Switzerland and South Korea as significant import partners adds some diversification, but the overall trajectory points toward greater dependence on a narrow set of Asian producers — even as the EU retains a competitive edge in the higher-value segments of the market.